Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care - An analysis of the OUTCOMEREA database

Morvan, A.-C.; Hengy, B.; Garrouste-Orgeas, M.; Ruckly, S.; Forel, J.-M.; Argaud, L.; Rimmelé, T.; Bedos, J.-P.; Azoulay, E.; Dupuis, C.; Mourvillier, B.; Schwebel, C.; Timsit, J.-F.; Zahar, J.-R.; Darmon, M.; Clec'H, C.; Alberti, C.; Bailly, S.; Vannieuwenhuyze, A.; Hernu, R.; Adrie, C.; Agasse, C.; Allaouchiche, B.; Andremont, O.; Andreu, P.; Ara-Somohano, C.; Barbier, F.; Boyer, D.; Baudry, T.; Bedel, J.; Bohé, J.; Bouadma, L.; Bourenne, J.; Brule, N.; Brétonnière, C.; Chemouni, F.; Cheval, C.; Carvelli, J.; Coupez, E.; Cour, M.; De Montmollin, E.; Dopeux, L.; Dumenil, A.-S.; Forel, J.-M.; Gainnier, M.; Garret, C.; Goldgran-Tonedano, D.; Grangé, S.; Gros, A.; Hammed, H.; Haouache, A.; Hissem, T.; Ha, V. H. T.; Jochmans, S.; Joffredo, J.-B.; Kallel, H.; Lacave, G.; Laurent, V.; Lautrette, A.; Magalhaes, C. L. B. E.; Lemiale, V.; Marcotte, G.; Lebut, J.; Lugosi, M.; Merceron, S.; Misset, Benoît; Neuville, M.; Nicolet, L.; Oziel, J.; Papazian, L.; Patrier, J.; Planquette, B.; Radjou, A.; Simon, M.; Sonneville, R.; Reignier, J.; Souweine, B.; Siami, S.; Terzi, N.; Troché, G.; Thuong, M.; Thierry, G.; Venot, M.; Yaacoubi, S.; Zambon, O.; Fournier, J.; Bagur, S.; Adda, M.; Vindrieux, V.; De La Salle, S.; Enguerrand, P.; Gobert, V.; Guessens, S.; Merle, H.; Kaddour, N.; Berthe, B.; Bekkhouche, S.; Mellouk, K.; Lebrazic, M.; Ouisse, C.; Maugars, D.; Aparicio, C.; Theodose, I.; Nouacer, M.; Deiler, V.; Lamara, F.; Moussa, M.; Mouaci, A.; Viguier, N.

doi:10.1186/s13054-019-2581-8

Article (Scientific journals)

Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care - An analysis of the OUTCOMEREA database

Morvan, A.-C.; Hengy, B.; Garrouste-Orgeas, M. et al.

2019 • In Critical Care, 23 (1)

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/245107

DOI
10.1186/s13054-019-2581-8

PubMed
31492201

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

morvan enterocoque peritonitis cc 2019 bm.pdf

Publisher postprint (747.92 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Antibiotic therapy; Enterococcus spp.; Intensive care; Intraabdominal infections; Mortality

Abstract :

[en] Introduction: Enterococcus species are associated with an increased morbidity in intraabdominal infections (IAI). However, their impact on mortality remains uncertain. Moreover, the influence on outcome of the appropriate or inappropriate status of initial antimicrobial therapy (IAT) is subjected to debate, except in septic shock. The aim of our study was to evaluate whether an IAT that did not cover Enterococcus spp. was associated with 30-day mortality in ICU patients presenting with IAI growing with Enterococcus spp. Material and methods: Retrospective analysis of French database OutcomeRea from 1997 to 2016. We included all patients with IAI with a peritoneal sample growing with Enterococcus. Primary endpoint was 30-day mortality. Results: Of the 1017 patients with IAI, 76 (8%) patients were included. Thirty-day mortality in patients with inadequate IAT against Enterococcus was higher (7/18 (39%) vs 10/58 (17%), p = 0.05); however, the incidence of postoperative complications was similar. Presence of Enterococcus spp. other than E. faecalis alone was associated with a significantly higher mortality, even greater when IAT was inadequate. Main risk factors for having an Enterococcus other than E. faecalis alone were as follows: SAPS score on day 0, ICU-acquired IAI, and antimicrobial therapy within 3 months prior to IAI especially with third-generation cephalosporins. Univariate analysis found a higher hazard ratio of death with an Enterococcus other than E. faecalis alone that had an inadequate IAT (HR = 4.4 [1.3-15.3], p = 0.019) versus an adequate IAT (HR = 3.1 [1.0-10.0], p = 0.053). However, after adjusting for confounders (i.e., SAPS II and septic shock at IAI diagnosis, ICU-acquired peritonitis, and adequacy of IAT for other germs), the impact of the adequacy of IAT was no longer significant in multivariate analysis. Septic shock at diagnosis and ICU-acquired IAI were prognostic factors. Conclusion: An IAT which does not cover Enterococcus is associated with an increased 30-day mortality in ICU patients presenting with an IAI growing with Enterococcus, especially when it is not an E. faecalis alone. It seems reasonable to use an IAT active against Enterococcus in severe postoperative ICU-acquired IAI, especially when a third-generation cephalosporin has been used within 3 months. © 2019 The Author(s).

Disciplines :

Anesthesia & intensive care

Author, co-author :

Morvan, A.-C.; Department of Anesthesiology and Critical Care Medicine, Hospices Civils de Lyon, Edouard Herriot Teaching Hospital, 5 place d'Arsonval, Lyon, 69003, France

Hengy, B.; Department of Anesthesiology and Critical Care Medicine, Hospices Civils de Lyon, Edouard Herriot Teaching Hospital, 5 place d'Arsonval, Lyon, 69003, France

Garrouste-Orgeas, M.; Polyvalent ICU, St Joseph Hospital, Paris, France

Ruckly, S.; UMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, INSERM Paris, Diderot University, Sorbonne Paris Cité, Paris, France

Forel, J.-M.; Medical ICU, Respiratory Distress and Severe Infections, Nord Hospital, URMITE CNRS, UMR 6236, Aix-Marseille University, AP-HM, Marseille, France

Argaud, L.; Medical ICU, Hospices Civils de Lyon, Edouard Herriot Teaching Hospital, Lyon, France

Rimmelé, T.; Department of Anesthesiology and Critical Care Medicine, Hospices Civils de Lyon, Edouard Herriot Teaching Hospital, 5 place d'Arsonval, Lyon, 69003, France

Bedos, J.-P.; Intensive Care Department, GHT Sud Yvelines, Centre Hospitalier de Versailles, Site André Mignot, Le Chesnay, Cedex, France

Azoulay, E.; Medical ICU, APHP, Saint-Louis Hospital, ECSTRA Team, Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris, France

Dupuis, C.

More authors (99 more)

Language :

English

Title :

Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care - An analysis of the OUTCOMEREA database

Publication date :

2019

Journal title :

Critical Care

ISSN :

1364-8535

eISSN :

1466-609X

Publisher :

BioMed Central Ltd.

Volume :

Issue :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 February 2020

Statistics

Number of views

89 (5 by ULiège)

Number of downloads

61 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Vincent J-L, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-53.
Riché FC, Dray X, Laisné M-J, Matéo J, Raskine L, Sanson-Le Pors M-J, et al. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care Lond Engl. 2009;13(3):R99.
Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34(3):646-52.
Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, et al. The microbiology of postoperative peritonitis. Clin Infect Dis. 2001;33(9):1513-9.
Montravers P, Dupont H, Leone M, Constantin J-M, Mertes P-M. Société française d'anesthésie et de réanimation (Sfar), et al. Guidelines for management of intra-abdominal infections. Anaesth Crit Care Pain Med. 2015;34(2):117-30.
Dupont H, Montravers P, Mohler J, Carbon C. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect Immun. 1998;66(6):2570-5.
Koch S, Hufnagel M, Theilacker C, Huebner J. Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine. 2004;22(7):822-30.
Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiol Read Engl. 2009;155(Pt 6):1749-57.
Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J. Pathogenicity of enterococci in a rat model of fecal peritonitis. J Infect Dis. 1989;160(1):142-5.
Montravers P, Andremont A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis. 1994;169(4):821-30.
Montravers P, Mohler J, Saint Julien L, Carbon C. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun. 1997;65(1):144-9.
Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, et al. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery. 1995;118(4):716-21 discussion 721-723.
Wacha H, Hau T, Dittmer R, Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group Langenbecks Arch Surg. 1999;384(1):24-32.
Sitges-Serra A, López MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg. 2002;89(3):361-7.
Gauzit R, Péan Y, Barth X, Mistretta F, Lalaude O, Top Study Team. Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study. Surg Infect. 2009;10(2):119-27.
Cercenado E, Torroba L, Cantón R, Martínez-Martínez L, Chaves F, García-Rodríguez JA, et al. Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol. 2010;48(2):456-9.
Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother. 2002;50(4):569-76.
Dupont H, Friggeri A, Touzeau J, Airapetian N, Tinturier F, Lobjoie E, et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011;66(10):2379-85.
Theunissen C, Cherifi S, Karmali R. Management and outcome of high-risk peritonitis: a retrospective survey 2005-2009. Int J Infect Dis. 2011;15(11):e769-73.
Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63(4):785-94.
Kaffarnik MF, Urban M, Hopt UT, Utzolino S. Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care. 2012;20(1):37-48.
Lautrette A, Garrouste-Orgeas M, Bertrand P-M, Goldgran-Toledano D, Jamali S, Laurent V, et al. Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea research group. Intensive Care Med. 2015;41(10):1763-72.
Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957-63.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg. 1985;202(6):685-93.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-77.
Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23(3):486-94.
Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI, et al. Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection. Intensive Care Med. 2018;44(8):1203-11.
Röhrborn A, Wacha H, Schöffel U, Billing A, Aeberhard P, Gebhard B, et al. Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial. Surg Infect. 2000;1(2):95-107.
Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med. 2001;135(7):484-92.
Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214(5):543-9.
Sturkenboom MCJM, Goettsch WG, Picelli G. in 't Veld B, Yin DD, de Jong RB, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60(4):438-43.
Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529-35.
Cattan P, Yin DD, Sarfati E, Lyu R, De Zelicourt M, Fagnani F. Cost of care for inpatients with community-acquired intra-abdominal infections. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2002;21(11):787-93.
Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2004;23(9):682-7.
Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, Biffl WL, Boermeester MA, et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg WJES. 2017;12:22.
Solomkin JS. Evaluating evidence and grading recommendations: the SIS/IDSA guidelines for the treatment of complicated intra-abdominal infections. Surg Infect. 2010;11(3):269-74.
Kang C-I, Chung DR, Ko KS, Peck KR, Song J-H. Korean Network for the Study of Infectious Diseases (KONSID). Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli. Scand J Infect Dis. 2011;43(3):202-8.
Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20(2):296-301.
Suppola JP, Kuikka A, Vaara M, Valtonen VV. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia. Scand J Infect Dis. 1998;30(2):153-7.
Conde-Estévez D, Grau S, Albanell J, Terradas R, Salvadó M, Knobel H. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients. Eur J Clin Microbiol Infect Dis. 2011;30(1):103-8.
Gudiol C, Ayats J, Camoez M, Domínguez MÁ, García-Vidal C, Bodro M, et al. Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One. 2013;8(9):e74734.
Billington EO, Phang SH, Gregson DB, Pitout JDD, Ross T, Church DL, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76-82.
Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg. 2003;27(4):379-84.
Solomkin JS, Ristagno RL, Das AF, Cone JB, Wilson SE, Rotstein OD, et al. Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections. Clin Infect Dis. 2013;56(12):1765-73.